Advertisement

Metabolic Brain Disease

, Volume 33, Issue 4, pp 1165–1173 | Cite as

A novel compound-primed multiplex ARMS-PCR (CPMAP) for simultaneous detection of common PAH gene mutations

  • Maryam Shaykholeslam Esfahani
  • Ehsan Shaykholeslam Esfahani
  • Sadeq Vallian
Original Article
  • 85 Downloads

Abstract

In this study, we introduce a novel compound-primed multiplex ARMS PCR (CPMAP) for simultaneous detection of common PAH gene mutations. This approach was used successfully for simultaneous identification of six most common PAH gene mutations in 137 phenylketonuria patients in the Iranian population. A total of six normal and six mutant allele-specific primers and 4 common primers containing a tag sequence of 12 base pair at the 5ˊ-end were designed and used in two separate optimized multiplex ARMS reactions followed by hot-start PCR. The products were separated and visualized on 3% agarose gel. The CPMAP genotyping data were completely in accordance with the direct sequencing results. The CPMAP suggests a reliable, economical and rapid method for simultaneous detection of PAH point mutations using conventional PCR, which could be applied for diagnosis of other gene mutations.

Keywords

Multiplex ARMS-PCR Compound primer Phenylalanine hydroxylase mutations Phenylketonuria 

Notes

Acknowledgements

This study was supported by University of Isfahan institutional review board (IRB) for research and ethics approval (Approval Ref No. 790205). We are immensely grateful to Dr. Austin J Carlson for constructive and thorough proofreading and English language editing of our manuscript.

Funding

This study was supported by University of Isfahan institutional review board (IRB) for research and ethics approval (Approval Ref No. 790205).

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflicts of interest.

References

  1. Ajami N, Kazeminezhad SR, Foroughmand AM, Hasanpour M, Aminzadeh M (2013) A preliminary mutation analysis of phenylketonuria in southwest Iran. Genet Mol Res 12:4958–4966CrossRefPubMedGoogle Scholar
  2. Alibakhshi R, Moradi K, Mohebbi Z, Ghadiri K (2014) Mutation analysis of PAH gene in patients with PKU in western Iran and its association with polymorphisms: identification of four novel mutations. Metab Brain Dis 29:131–138CrossRefPubMedGoogle Scholar
  3. Aulehla-Scholz C, Heilbronner H (2003) Mutational spectrum in German patients with phenylalanine hydroxylase deficiency. Hum Mutat 21:399–400CrossRefPubMedGoogle Scholar
  4. Biglari A, Saffari F, Rashvand Z, Alizadeh S, Najafipour R, Sahmani M (2015) Mutations of the phenylalanine hydroxylase gene in Iranian patients with phenylketonuria. SpringerPlus 4:542CrossRefPubMedPubMedCentralGoogle Scholar
  5. Blievernicht JK, Schaeffeler E, Klein K, Eichelbaum M, Schwab M, Zanger UM (2007) MALDI-TOF mass spectrometry for multiplex genotyping of CYP2B6 single-nucleotide polymorphisms. Clin Chem 53:24–33CrossRefPubMedGoogle Scholar
  6. Bonyadi M, Omrani O, Moghanjoghi SM, Shiva S (2010) Mutations of the phenylalanine hydroxylase gene in Iranian Azeri Turkish patients with phenylketonuria. Genet Test Mol Biomarkers 14:233–235CrossRefPubMedGoogle Scholar
  7. Brownie J, Shawcross S, Theaker J, Whitcombe D, Ferrie R, Newton C, Little S (1997) The elimination of primer-dimer accumulation in PCR. Nucleic Acids Res 25:3235–3241CrossRefPubMedPubMedCentralGoogle Scholar
  8. Edwards MC, Gibbs RA (1994) Multiplex PCR: advantages, development, and applications. Genome Res 3:S65–S75CrossRefGoogle Scholar
  9. Ferrie RM, Schwarz MJ, Robertson NH, Vaudin S, Super M, Malone G, Little S (1992) Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene. Am J Hum Genet 51:251PubMedPubMedCentralGoogle Scholar
  10. Fortina P et al (1992) Non-radioactive detection of the most common mutations in the cystic fibrosis transmembrane conductance regulator gene by multiplex allele-specific polymerase chain reaction. Hum Genet 90:375–378CrossRefPubMedGoogle Scholar
  11. Ghiasvand NM et al (2009) Prevalence of classical phenylketonuria in mentally retarded individuals in Iran. J Inherit Metab Dis 32:283–287CrossRefGoogle Scholar
  12. Guldberg P et al (1998) A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Med Genet 63:71–79Google Scholar
  13. Habib A, Fallahzadeh MH, Kazeroni HR, Ganjkarimi AH (2015) Incidence of phenylketonuria in Southern Iran. Iran J Med Sci 35:137–139Google Scholar
  14. Hamzehloei T, Hosseini SA, Vakili R, Mojarad M (2012) Mutation spectrum of the PAH gene in the PKU patients from Khorasan Razavi province of Iran. Gene 506:230–232CrossRefPubMedGoogle Scholar
  15. Hanley WB (2004) Adult phenylketonuria. Am J Med 117:590–595CrossRefPubMedGoogle Scholar
  16. Henegariu O, Heerema NA, Dlouhy SR, Vance GH, Vogt PH (1997) Multiplex PCR: critical parameters and step-by-step protocol. Biotechniques 23:504–511PubMedGoogle Scholar
  17. Inagaki S et al (2004) A new 39-plex analysis method for SNPs including 15 blood group loci. Forensic Sci Int 144:45–57CrossRefPubMedGoogle Scholar
  18. Kleiman S et al (1994) Origins of hyperphenylalaninemia in Israel. Eur J Hum Genet 2:24–34CrossRefPubMedGoogle Scholar
  19. Koochmeshgi J, Bagheri A, Hosseini-Mazinani SM (2002) Incidence of phenylketonuria in Iran estimated from consanguineous marriages. J Inherit Metab Dis 25:80–81CrossRefPubMedGoogle Scholar
  20. Kostandyan N et al (2011) The spectrum of phenylketonuria genotypes in the Armenian population: identification of three novel mutant PAH alleles. Mol Genet Metab 104:S93–S96CrossRefPubMedGoogle Scholar
  21. Kwok S, Kellogg DE, McKinney N, Spasic D, Goda L, Levenson C, Sninsky JJ (1990) Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res 18:999–1005CrossRefPubMedPubMedCentralGoogle Scholar
  22. Little S (2001) Amplification refractory mutation system (ARMS) analysis of point mutations. Curr Protoc Hum Genet:9.8. 1–9.8. 12Google Scholar
  23. Loeber JG (2007) Neonatal screening in Europe; the situation in 2004. J Inherit Metab Dis 30:430–438CrossRefPubMedGoogle Scholar
  24. Lorenz TC (2012) Polymerase chain reaction: basic protocol plus troubleshooting and optimization strategies. J Vis Exp 63:3998Google Scholar
  25. Markoulatos P, Samara V, Siafakas N, Plakokefalos E, Spyrou N, Moncany ML (1999) Development of a quadriplex polymerase chain reaction for human cytomegalovirus detection. J Clin Lab Anal 13:99–105CrossRefPubMedGoogle Scholar
  26. Markoulatos P, Siafakas N, Moncany M (2002) Multiplex polymerase chain reaction: a practical approach. J Clin Lab Anal 16:47–51CrossRefPubMedGoogle Scholar
  27. Multer GL, Boynton KA (1995) PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies. Nucleic Acids Res 23:1411–1418CrossRefGoogle Scholar
  28. Old JM (1996) Hemoglobinopathies: community clues to mutation detection. In: Elles R (ed) Methods in Molecular Medicine: Molecular Diagnosis of Genetic Diseases. Humana Press, Totowa, pp 169–183.  https://doi.org/10.1385/0-89603-346-5:169 CrossRefGoogle Scholar
  29. Özalp I, Coşkun T, Ceyhan M, Tokol S, Oran O, Erdem G, Takinalp G, Durmuş Z, Tarikahya Y (1986) Incidence of phenylketonuria and hyperphenylalaninaemia in a sample of the Turkish newborn population. In: Addison GM, Harkness RA, Isherwood DM, Pollitt RJ (eds) Practical Developments in Inherited Metabolic Disease: DNA Analysis, Phenylketonuria and Screening for Congenital Adrenal Hyperplasia: Proceedings of the 23rd Annual Symposium of the SSIEM, Liverpool, September 1985. Springer Netherlands, Dordrecht, pp 237–239.  https://doi.org/10.1007/978-94-009-4131-1_35
  30. Ozgüç M, Ozalp I, Coşkun T, Yilmaz E, Erdem H, Ayter S (1993) Mutation analysis in Turkish phenylketonuria patients. J Med Genet 30:129–130CrossRefPubMedPubMedCentralGoogle Scholar
  31. Rithidech KN, Dunn JJ, Gordon CR (1997) Combining multiplex and touchdown PCR to screen murine microsatellite polymorphisms. Biotechniques 23:36, 40, 42, 44Google Scholar
  32. Ruano G, Fenton W, Kidd KK (1989) Biphasic amplification of very dilute DNA samples via'booster'PCR. Nucleic Acids Res 17:5407CrossRefPubMedPubMedCentralGoogle Scholar
  33. Scriver CR, Kaufman S (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. The Metabolic and Molecular Bases of Inherited Diseases:1667-1724Google Scholar
  34. Senemar S, Ganjekarimi H, Fathzadeh M, Tarami B, Bazrgar M (2009) Epidemiological and clinical study of Phenylketonuria (PKU) disease in the National Screening Program of Neonates, Fars province, Southern Iran. Iran J Public Health 38:58–64Google Scholar
  35. Shi MM (2001) Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies. Clin Chem 47:164–172PubMedGoogle Scholar
  36. Shi X, Tang C, Zhou D, Sun J, Lu Z (2009) PCR product microarray based on polyacrylic acid-modified surface for SNP genotyping. Electrophoresis 30:1286–1296CrossRefPubMedGoogle Scholar
  37. Shuber AP, Grondin VJ, Klinger KW (1995) A simplified procedure for developing multiplex PCRs. Genome Res 5:488–493CrossRefPubMedGoogle Scholar
  38. Toubanaki DK, Christopoulos TK, Ioannou PC, Flordellis CS (2008) Identification of single-nucleotide polymorphisms by the oligonucleotide ligation reaction: a DNA biosensor for simultaneous visual detection of both alleles. Anal Chem 81:218–224CrossRefGoogle Scholar
  39. Vallian S, Barahimi E, Moeini H (2003) Phenylketonuria in Iranian population: a study in institutions for mentally retarded in Isfahan. Mutat Res 526:45–52CrossRefPubMedGoogle Scholar
  40. Walter JΗ, White FJ (2004) Blood phenylalanine control in adolescents with phenylketonuria. Int J Adolesc Med Health 16:41–45CrossRefPubMedGoogle Scholar
  41. Yanagawa T, Koga H (2009) Modified multiple primer extension method. Single Nucleotide Polymorphisms: Methods and Protocols 425–435Google Scholar
  42. Zare-Karizi S, Hosseini-Mazinani SM, Khazaei-Koohpar Z, Seifati S, Shahsavan-Behboodi B, Akbari MT, Koochmeshgi J (2011) Mutation spectrum of phenylketonuria in Iranian population. Mol Genet Metab 102:29–32CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Maryam Shaykholeslam Esfahani
    • 1
  • Ehsan Shaykholeslam Esfahani
    • 2
  • Sadeq Vallian
    • 1
  1. 1.Division of Genetics, Department of Biology, Faculty of ScienceUniversity of IsfahanIsfahanIran
  2. 2.Division of Biotechnology, Department of Agricultural Biotechnology, Faculty of AgricultureIsfahan University of TechnologyIsfahanIran

Personalised recommendations